The relationship of arterial blood flow and venous volume to venous flow velocity was studied in normal subjects. The effects of current modes of treatment in venous thrombosis and of a vasodilator drug on venous flow velocity were also investigated. The present study investigated the physiological factors that affect the velocity of venous blood flow; the effects of therapies currently used in venous thrombosis on venous blood flow velocity, arterial blood flow, and venous volume; and the effect of a vasodilator drug on venous blood flow velocity.
ARTERIAL BLOOD FLOW and venous tone in the extremities of man have been the subject of extensive physiologic and pharmacologic study but venous flow velocity has received little attention. Stanton et al.' measured linear velocity of venous flow by timing the movement of radio-opaque dye injections; a simpler technique described by Wright et al.2 using the transit time of a radioisotope, has been used in recent years. It has been shown that head-down tilting and exercise increase, while upright posture and immobilization decrease, venous flow velocity.3' 4 An increased velocity has also been found with external compression of the limbs.5 6 However, the contribution of arterial blood flow and of changes in vein caliber to venous flow velocity have not been determined. Stimuli may affect either the arterial or venous system or both; for instance, epinephrine increases muscle blood flow but constricts veins.
Among the factors precipitating venous thrombosis,
Angiotensin
Cold 131I albumin a slowing of venous flow is probably one of, if not the most, significant.7 Although local heat and sometimes local cold have been used for years in the treatment of venous thrombosis, their effect on venous flow velocity has not been studied and has no scientific basis. The hemodynamic actions of heparin, a valuable anticoagulant in treatment, are also unknown except for conflicting reports regarding its effect on limb blood flow. [8] [9] [10] The present study investigated the physiological factors that affect the velocity of venous blood flow; the effects of therapies currently used in venous thrombosis on venous blood flow velocity, arterial blood flow, and venous volume; and the effect of a vasodilator drug on venous blood flow velocity.
Methods
Total calf blood flow and venous volume were measured by venous occlusion plethysmography on lightly clothed subjects in a 24.5°C constant temperature room. Average age of these normal volunteers was 24 years. The supine subjects were positioned to maintain the posterior aspect of the calf approximately at heart level. The calf was enclosed in a plethysmograph filled with water maintained at a temperature of 340 C. 2. In 21 subjects, a catheter was also inserted into the femoral artery for infusion by a constant infusion pump of 0.2 to 1.5 gg/min of isoproterenol in 11 subjects or 0.125 to 0.25 ,g/min of angiotensin in ten subjects. The doses were adjusted to increase or decrease calf blood flow with no change in venous volume, pulse rate, or blood pressure. Before and following drug administration at a rate of 1 to 2 ml/min, normal saline was infused at the same rate. After a stable increase or decrease in calf blood flow was obtained during drug administration, venous volume and flow velocity were determined.
3. In 20 subjects, controls were determined with 340 C water in the plethysmograph. The water was changed to 420 C and measurements repeated at 10 and 25 minutes. The water was then changed to 100 C and the studies repeated at 10 and 25 mi utes.
4. In ten subjects, after controls were determined, 10,000 units of heparin were given intravenously. Calf blood flow, venous volume, and venous flow velocity were obtained at 30, 60, and 90 minutes.
5. In six subjects, flow and volume parameters were determined 5 and 20 minutes after the intravenous administration of 7.5 mg of nylidrin hydrochloride. In eight fasting subjects, venous flow velocities were measured 30, 60, and 90 minutes after 12 mg of nylidrin hydrochloride were administered orally. No plethysmograph was used in these eight experiments and the lower extremity was not elevated above heart level.
Statistical analyses were performed using the Wilcoxon signed ranks test. Mainland discusses the advantages of signed ranks test compared to other statistical methods, depending upon Gaussian distribution.'2
Results

Local Intravenous Epinephrine
In ten experiments, epinephrine infused into the saphenous vein decreased venous volume and increased venous flow velocity (P < 0.01) while calf blood flow did not change significantly (table 1) . Postinfusion measurements obtained 15 minutes later demonstrated an increase in venous volume (4.0 to 4.5 ml, P < 0.01) and slowing of venous flow velocity (27.5 to 12.4 cm/sec, P < 0.05). No significant changes occurred in pulse rate or mean blood pressure during these experiments. Histamine, bradykinin, and sodium nitroprusside were infused into the saphenous vein of two subjects each but no changes in venous volume occurred. Therefore, we were not able to determine the effect of dilating the veins on venous flow velocity.
Intra-arterial Isoproterenol or Angiotensin
In 11 subjects, intra-arterial isoproterenol increased calf blood flow (P < 0.01) but did not significantly affect venous volume or venous flow velocity (table 1) . No significant change occurred in mean blood pressure while pulse rate showed a small increase (P < 0.05). In ten subjects, intra-arterial angiotensin decreased calf blood flow (P < 0.01) but did not significantly affect venous volume or venous flow Circulation, Volume 52, July 1975 
